Center for U.S. Policy
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • Internships
Category

X the X Waiver

Congressional Letter to Biden on X Waiver

Congressional Letter to Biden on X Waiver

External Report February 8, 2021
Biden To Reverse Trump X Waiver Policy

Biden To Reverse Trump X Waiver Policy

News January 25, 2021
Federal Gov’t Expands Access to Buprenorphine for OUD

Federal Gov’t Expands Access to Buprenorphine for OUD

News January 14, 2021
DATA 2000 Stymies Access for Black Patients

DATA 2000 Stymies Access for Black Patients

News October 23, 2020
Congress Should Pass MAT Act To Save Lives

Congress Should Pass MAT Act To Save Lives

Third-Party Opinion August 9, 2020
Pandemic Provides Avenue for Deregulation of OUD Treatment

Pandemic Provides Avenue for Deregulation of OUD Treatment

Third-Party Opinion May 28, 2020
Methadone Deregulation Should Continue Post-Pandemic

Methadone Deregulation Should Continue Post-Pandemic

Third-Party Opinion May 24, 2020
Coronavirus Compels Us To Reconsider X Waiver

Coronavirus Compels Us To Reconsider X Waiver

Third-Party Opinion April 7, 2020
COVID-19: OUD Practice and Policy Considerations

COVID-19: OUD Practice and Policy Considerations

Third-Party Opinion April 3, 2020
Pandemic Highlights Need for OUD Treatment Reform

Pandemic Highlights Need for OUD Treatment Reform

Third-Party Opinion March 17, 2020
Let's Ease Restrictions on Buprenorphine for OUD

Let’s Ease Restrictions on Buprenorphine for OUD

Third-Party Opinion March 5, 2020
Few Primary Care Providers Can Prescribe Buprenorphine for OUD

Few Primary Care Providers Can Prescribe Buprenorphine for OUD

News January 6, 2020
Loading...
« Previous
Print page

© 2025 Center for U.S. Policy. All Rights Reserved.